Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis.
about
Angiotensin II in inflammation, immunity and rheumatoid arthritisDoes endothelial dysfunction correlate with endocrinal abnormalities in patients with polycystic ovary syndrome?Assessment of endothelial function as a marker of cardiovascular risk in patients with rheumatoid arthritis.Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatmentCardiovascular involvement in autoimmune diseases.Cardiovascular risk management in patients with inflammatory arthritis: what is good for the joint is good for the heart and vice versa!Rheumatoid arthritis patients with active disease and no history of cardiac pathology have higher brain natriuretic peptide (BNP) levels than patients with inactive disease or healthy control subjects.Tailored antihypertensive drug therapy prescribed to older women attenuates circulating levels of interleukin-6 and tumor necrosis factor-αCentral Pressure and Biomarker Responses to Renin Inhibition with Hydrochlorothiazide and Ramipril in Obese Hypertensives: The ATTAIN Study.What is the future of targeted therapy in rheumatology: biologics or small molecules?Preventing Heart Failure in Inflammatory and Immune DisordersThe assessment of endothelial function: from research into clinical practice.Treatment with the arginase inhibitor Nw-hydroxy-nor-L-arginine restores endothelial function in rat adjuvant-induced arthritis.Vasculoprotective Effects of Dietary Cocoa Flavanols in Patients on Hemodialysis: A Double-Blind, Randomized, Placebo-Controlled Trial.Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosisRamipril attenuates lipid peroxidation and cardiac fibrosis in an experimental model of rheumatoid arthritis.Response to 'Ramipril attenuates lipid peroxidation and cardiac fibrosis in an experimental model of rheumatoid arthritis'.Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion.Regulation of T-cell function by endogenously produced angiotensin II.Comparative effects of angiotensin receptor blockade and ACE inhibition on the fibrinolytic and inflammatory responses to cardiopulmonary bypassAngiotensin II type 2 receptor correlates with therapeutic effects of losartan in rats with adjuvant-induced arthritis.Targeting inflammation as a therapeutic strategy in accelerated atherosclerosis in rheumatoid arthritis.Cardiovascular risk in rheumatoid arthritis and systemic autoimmune rheumatic disorders: a suggested model of preventive strategy.CD154: the atherosclerotic risk factor in rheumatoid arthritis?Benefits and pitfalls of cardiovascular medication in seniors.Prevention of Stroke in Rheumatoid Arthritis.Adherence to cardiovascular prevention strategies in patients with rheumatoid arthritis.Marked underdiagnosis and undertreatment of hypertension and hypercholesterolaemia in rheumatoid arthritis.Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synoviumPrimary prevention of myocardial infarction with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertensive patients with rheumatoid arthritis-A nationwide cohort study.Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the Implementation of Cardiovascular Risk Management in Rheumatoid Arthritis project.Prevention of stroke in rheumatoid arthritis.Hypertension as a cardiovascular risk factor in autoimmune rheumatic diseases.Angiotensin-(1-7) decreases LPS-induced inflammatory response in macrophages.
P2860
Q26991828-9035F51F-3745-4700-BC24-AD3AFB7510F8Q28079172-D227D2A1-B888-4C59-8C75-0BE39C5032F0Q33655500-0A2266E9-E2AC-47CB-BCDC-321A45F07F4DQ33943374-B5D66178-7EE1-497A-81C3-A959A03464C5Q34081242-A58ADD7E-AB36-40D9-81BF-B2AF0E4650B9Q34167653-68D50155-7078-4489-9530-178C4C321AB8Q34357253-CF2F6DB2-4C99-4148-BE7E-A4CCF9AAA61EQ34977437-1B3DC904-2380-428A-B9C7-77D698DC0CF6Q35005395-6A36973C-07E8-46D7-AFF8-9E28CEF2F479Q35118364-7CC49988-0425-45C1-89F5-17B8D7E86504Q35994802-CE94D659-DC86-4C88-B5B8-204F816897D6Q36190146-BCCA8372-123A-466F-BE8D-A9DC396C5B18Q36246065-AA9E0617-89F3-456F-9ADB-394F8FCDD30BQ36432925-16F9AF9C-6B45-4778-AA33-0BB031F81D80Q36511541-583E0EC6-9FBB-4A07-9AD6-58C6C4BB1983Q36633235-CDD5C7D7-0CAD-426C-A585-7D0EACDA6334Q36903436-C06B38D6-7ED7-46BE-BD81-B22847A5818BQ37058791-1CE4775F-64DA-4696-B469-55FDA6832244Q37100479-8E13943B-C637-44F0-9BEA-64143D92AA0CQ37294384-DD1F433D-481C-47E3-B8CF-C9AE26E6E371Q37557554-0E28080C-C95C-4DD5-8573-F20E0BDF7E4AQ37765620-0FAFD573-A24F-4B0C-8A14-D1B640675034Q37829385-01D2BF65-3649-4D66-AA26-043E9B227402Q38083874-D339699F-EFBF-4B6B-8309-653A21888642Q38120998-37B55922-CEBF-40C1-B462-0A2FAE606CBAQ38612651-637CE24C-0F85-420A-BD77-EA5BB51D953FQ40742537-CBA78602-A55F-48DB-B528-857374844AF7Q40835686-BB05F4F7-492D-4A66-B4A3-5662E3DEDBD2Q42378890-E6D0D90F-0501-4ED8-A544-2FEF8ECD5C32Q47095887-6DAC7171-EE9D-4014-9E62-44B5FE2B1C33Q47859328-5459A0CC-F9EB-4C3A-9DE2-8319F82BE62AQ53502883-1569D804-5024-4989-97BE-6BC85FCE18C4Q54060732-F9C4EF04-A092-459A-B277-C42AFA87A39BQ54573248-4B6AA57A-A94F-4310-A8D9-14E89EDAC1BF
P2860
Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Angiotensin-converting enzyme ...... ction in rheumatoid arthritis.
@en
Angiotensin-converting enzyme ...... ction in rheumatoid arthritis.
@nl
type
label
Angiotensin-converting enzyme ...... ction in rheumatoid arthritis.
@en
Angiotensin-converting enzyme ...... ction in rheumatoid arthritis.
@nl
prefLabel
Angiotensin-converting enzyme ...... ction in rheumatoid arthritis.
@en
Angiotensin-converting enzyme ...... ction in rheumatoid arthritis.
@nl
P2093
P1433
P1476
Angiotensin-converting enzyme ...... ction in rheumatoid arthritis.
@en
P2093
Adrian Forster
Daniel Périat
Frank Enseleit
Frank Hermann
Georg Noll
Isabella Sudano
Juerg Nussberger
Matthias Hermann
Michel Neidhart
Peter Künzler
P304
P356
10.1161/CIRCULATIONAHA.107.734384
P407
P577
2008-04-21T00:00:00Z